Utang jangka cendhak perusahaan: Bio-Rad Laboratories Inc (BIO)

Bio-Rad Laboratories (BIO) maintains a strong position in the production of diagnostic equipment despite risks associated with the reduction of venture capital. Short-term loan capital dynamics demonstrate stability, with the latest value recorded as 0.35. The company relies on loyal clients from the scientific and medical sectors, providing critical quality control systems without which clinics would lose their certification.

The selection of the issuer is based on an analysis of solvency and a comparison of liabilities against liquid assets. This indicator measures the total amount of loans maturing within twelve months, which, combined with the global sales diversification and logistics optimization of Bio-Rad Laboratories (BIO), allows for the assessment of cash gap risks by tracking credit obligations with a maturity of up to one year.